Vaccine Weekly articles from January 2002

Vaccine Weekly archives from January 2002

Modified Rhabdovirus Makes Effective Vector.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A modified form of the rabies virus may be the foundation for an effective HIV vaccine, researchers in the United States say. Heather D. Foley and...

Fibroblasts Useful Vectors For Gene Delivery After Surgical Injury.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Fibroblasts, which tend to congregate at the sites of injuries, are useful vectors for gene delivery, scientists in Japan have determined. It is not...

Ridding Cells Of Heat Shock Protein 70 Enhances Tumor Immunogenicity.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers in France may have discovered a better way to produce immunity against colon cancer cells, leading the way for the development of new tumor...

Pentavalent Vaccine Could Weaken Hepatitis B Vaccination Efforts.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new survey of pediatricians in the U.S. suggests efforts to increase compliance with hepatitis B vaccine recommendations could weaken if a pentavalent vaccine...

Study Measures Economic Benefits Of TB Vaccine.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- The Sequella Global Tuberculosis Foundation (SGTBF) has announced the results of a study performed by David M. Bishai and Daniel Mercer of the Johns Hopkins University, whose work was supported by a...

Transduced Dendritic Cells Inspire Antitumor Effect.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A growing body of evidence continues to point to transduced dendritic cells as important adjuvants for tumor vaccines. "Gene delivery to dendritic cells...

Protein Sciences Gets NIAID Contract For AIDS Vaccines.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Protein Sciences Corp. (PSC) has signed a contract with the National Institute of Allergy and Infections Diseases (NIAID) that provides for up to $76 million in funding through mid-2006 for development...

Resistant Genotypes Can Confound Research.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Rhesus macaques with genotypes naturally resistant to the simian form of HIV can confound the results of HIV vaccine studies, researchers warn. "Both...

Encouraging Results From Phase I Trial Of GVAX Cancer Vaccine.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., reported that a Phase I clinical trial of GVAX cancer vaccine in patients with refractory or relapsed acute myelogenous leukemia (AML) and preleukemia has demonstrated clinical...

Positive Phase III Clinical Results With Humanized Antibody Therapy.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc., (PDL) announced positive clinical results from the Phase III trial of its humanized antibody Zamyl (SMART M195) in patients with acute myeloid leukemia (AML). The trial...

AAMC Issues New Guidelines On Financial Conflicts Of Interest.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- The Association of American Medical Colleges (AAMC) has released the first report of its Task Force on Conflicts of Interest in Clinical Research "Protecting Subjects, Preserving Trust, Promoting...

Imperial College, Chelsea, Westminster Healthcare To Coordinate Trials.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Imperial College and Chelsea and Westminster Healthcare NHS Trust will be at the heart of vital worldwide research into vaccines to combat HIV. Thanks to a unique partnership with the International...

Mosquito-Borne Malady May Be Made More Deadly.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- A new study claims that some future malaria vaccines that don't entirely wipe out the disease might unintentionally serve to make it more deadly. The study uses mathematical analysis to examine the...

U.S. Trial Starts For Recombinant Human Albumin Vaccines.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Merck's investigational new drug application (IND) for this vaccine became effective in December 2001 and the preparations for the pivotal clinical trial are complete. This therapeutic development...

MedImmune Gets FluMist Rights In Agreement With Aviron.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc. and Aviron have entered into a definitive merger agreement under which MedImmune plans to acquire Aviron and add Aviron's FluMist to its product offerings. The deal is anticipated to...

Monoclonal Antibody Therapy Looks Promising.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO) announced the presentation of preclinical data on ProstaRex at the December 2001 American Association of Cancer Research (AACR) Special Conference, "New Discoveries in Prostate...

SkyePharma And Astralis Enter Agreements For Promising New Treatment.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- SkyePharma, Plc., and Astralis, Ltd., (ASTR) have signed several agreements concerning the formulation and development of Astralis' novel injectable vaccine therapy, Psoraxine, for the treatment of all...

HuMax-CD4 To Enter Phase III Studies.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that it has received permission from the U.S. Food and Drug Administration (FDA) to begin a Phase III study with HuMax-CD4 to treat patients with active rheumatoid arthritis (RA)...

Family Recalls Smallpox Claiming Mom, Says Vaccinations Should Resume.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Billie Raney was 21 when she stood on the sidewalk with her three grown sisters, watching morticians drag their mother out of the family home in Elsa, Texas, still wrapped in the sheets in which she had...

National Vaccine Information Center Releases Smallpox Report Opposing Forced Vaccination Plan.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- The National Vaccine Information Center (NVIC) has released a comprehensive report on smallpox and smallpox vaccine critical of model state legislation initiated by the U.S. Centers for Disease Control...

New Child Vaccine in High Demand.(Brief Article)
January 9, 2002... 2002 JAN 9 - (NewsRx.com & NewsRx.net) -- High demand for a new vaccine against childhood pneumonia, meningitis, and ear infections has led to a shortage around the country. The shortage of Prevnar should ease by the end of March 2002 said...

Interleukins Can Be Effective Adjuvants For Mucosal Administration.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A group of proinflammatory cytokines may be useful as adjuvants for nasally administered HIV vaccines, researchers in the United States report. "Safe and...

Researchers Develop New Method Of Delivery Vaccines.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Researchers at UT Southwestern Medical Center at Dallas have developed a quicker, more cost-efficient method of delivering dendritic cell-based vaccines - a discovery that moves antitumor vaccines...

Nef-Deleted Vaccine Strain Replicates In CD4 Cells.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A nef-deleted simian HIV (SIV) strain uses the same cells for replication as wild-type SIV, according to researchers in the United States and Europe. ...

Vaccine May Protect Against Mosquito-borne Disease.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- A vaccine made from the milk of genetically engineered mice has been shown to prevent monkeys from developing malaria. The same vaccine produced in goat's milk could protect millions from malaria,...

Cross-Reactive Memory Cells Recognize HCV Peptides After Influenza Exposure.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Vaccine developers need to keep in mind that cross-reactive memory cells can form in human hosts, producing an immune response to antigens the host has not...

New Vaccine Wards Off Recurring Urinary Tract Infections.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- A new vaccine shows promise in warding off recurring urinary tract infections in women who are plagued by several episodes a year. Most urinary infections are easily cured with antibiotics, but...

Structured Treatment Interruptions Evaluated In HIV Patients.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- by Michelle Marble, senior medical writer - Structured treatment interruptions (STIs) of antiretroviral therapy in HIV infected patients were the source of several discussions at the 41st Annual...

Antigenics Receives Milestone Payment from Elan Corp. for QS-21.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) has received a milestone payment from Elan Corp. (ELN) for its leading immune-stimulating adjuvant, QS-21, the only adjuvant utilized in an experimental Alzheimer disease...

America's Only Manufacturer Seeks FDA Approval To Ship.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- The nation's only manufacturer of an anthrax vaccine has expressed confidence it will soon win federal approval to distribute the vaccine. The U.S. Food and Drug Administration, which spent the...

Alexion Completes Phase I Dermatomyositis Pilot Safety Study.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., announced that it has completed a two-month Phase I pilot safety trial in dermatomyositis patients with its humanized monoclonal antibody C5 complement inhibitor, 5G1.1....

Army Anthrax Lab Security Called Lax.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Security has improved at an Army laboratory that works with anthrax since the deadly microbes were mailed to two senators, but during much of the 1990s, it was not stringent enough to prevent a...

Florida Media Company Employees Offered Anthrax Vaccine; Few Take.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- People possibly exposed to anthrax at the Boca Raton, Florida, offices of tabloid publisher American Media, Inc., were offered a vaccine taken from military supplies, but there were few takers. ...

Israel Has Anthrax Vaccine, Could Immunize Entire Population.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Israel has developed an anthrax vaccine and could produce enough to immunize the entire population within months, an Israeli newspaper reported December 20, 2001. The Haaretz daily reported that...

Suddenly, Refrigerators For Vaccines Very Popular.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- The same technology that keeps takeout pizza hot is being used to keep vaccines cool, bringing increased demand for the refrigeration units since the East Coast terrorist attacks. "Everybody is...

Drug Candidate INGN 201 Looks Promising.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., announced additional safety data for its p53 gene drug candidate, INGN 201, adenoviral-p53 at the 10th International Conference on Gene Therapy of Cancer held in San Diego,...

General Accounting Office Probes Tainted Medical Research.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Universities and federal health officials must do more to prevent financial conflicts that could taint biomedical research and harm human subjects, a congressional review says. The study by the...

NIAID, Merck To Collaborate On HIV Vaccine Development.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- The National Institute of Allergy and Infectious Diseases (NIAID), the leading HIV research component of the United States government, has entered into an agreement with Merck & Co. to collaborate on...

Second Phase II Clinical Trial Of MVA-HPV-IL2 Vaccine Initiated.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Transgene announced the initiation of a Phase II clinical trial of its immunotherapeutic MVA-HPV-IL2 vaccine candidate for the treatment of vulvar intraepithelial neoplasia (VIN3). The trial will...

Researchers Illuminate How The Body Handles Inflammation.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- After a decade of research, Michail Sitkovsky, PhD, and his coworkers at the National Institute of Allergy and Infectious Diseases (NIAID) may have answered one of the most perplexing questions in...

Clinical Data From Phase I/II GVAX Vaccine Trial Updated.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., reported further clinical data from its multicenter Phase I/II GVAX lung cancer vaccine trial that demonstrated a complete tumor response rate of 12% and a median response duration...

Immune Response Enhancer Improves Vaccine.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., announced the publication of clinical results of a malaria vaccine containing Antigenics' immune response enhancer, QS-21, which showed significant protection against the most...

Vical and Aventis Restructure Agreements.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur, the vaccine business of Aventis SA (AVE), is obtaining rights to use Vical, Inc.'s, patented gene delivery technologies for specific oncology applications. In exchange, Aventis...

Measles Nearly Eradicated In The West, CDC Says.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Measles has been all but wiped out in the Western Hemisphere, dropping from 250,000 cases in 1990 to fewer than 500 so far this year, health officials say. The U.S. Centers for Disease Control and...

Antex Launches Phase I Human Trial for Vaccine.(Brief Article)
January 16, 2002... 2002 JAN 16 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc., (ANX) has begun a Phase I human clinical trial for the second component of its combination Activax vaccine to prevent travelers' diseases caused by the consumption of...

Heat Shock Protein Gene Transfer Creates Systemic Response In Mice.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Tumor immunity can be generated with heat shock protein (HSP) gene therapy, but researchers caution that simultaneous administration with other...

Therapy Recognizes Receptor Mutation, Prevents New Melanoma Formation.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Duke University researchers say they have created a tumor vaccine that targets mutated receptors on malignant tumors but also circumvents abnormal immune...

Epitope Affinity Enhancement Can Improve Vaccine Efficacy.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have modified an HIV protein-based vaccine to improve its ability to trigger long-term immune responses. "Natural viral...

Military Immunization Associated With Increased Risk Of Diabetes.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- Data show that the rate of insulin-dependent diabetes in those entering the U.S. Navy is about the same as controls but reaches up to 5.5 times that of controls in women, and 2.5 times that of controls...

Group B Streptococcus Protein Target Limits Pathological Angiogenesis.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - New research shows the human hp59 gene or its protein HP59 could be used as a drug target or an antiangiogenesis vaccine. Researchers believe the membrane...

Early Cytotoxic T-Cell Responses Characterized.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Vaccine researchers in the United States have shed new light on the early cytotoxic T-cell response to HIV infection. "Cytotoxic T-lymphocyte (CTL)...

Therion Biologics and Ludwig Institute Initiate Study of Cancer Vaccine.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- The Ludwig Institute for Cancer Research has initiated the first European Phase I trial for Therion Biologics' two-component vaccine targeting the tumor antigen NY-ESO-1. In this study, the Ludwig...

Clinical Study Based On ESO-1 Tumor-Associated Antigen Initiated.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- The Ludwig Institute for Cancer Research has initiated the first European Phase I trial for Therion Biologics' two-component vaccine targeting the tumor antigen NY-ESO-1. In this study, the Ludwig...

Clinical Trial Data Encouraging.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- Two Harvard Medical School oncologists working with Genzyme Molecular Oncology presented preliminary data showing both clinical and immunologic responses from melanoma and breast cancer vaccine trials....

Childrens' DTP Vaccine Is In Short Supply.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- The national shortage of the vaccine that protects children against tetanus, diphtheria and whooping cough will continue through at least the middle of the year, the U.S. Centers for Disease Control...

South Korean Military To Buy Anthrax Vaccines.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- The South Korean military will buy anthrax vaccines for the first time next year as a precaution against possible biological terrorism, a Defense Ministry official said. The ministry will spend 2...

Study Identifies Signaling Gene For Immune Cells.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- More vigilant than minutemen, the immune system's T cells form one of the main lines of defense against infection and disease. A study by Dana-Farber investigators is reversing scientists'...

Positive Trial Results For Intraocular Drug Delivery.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., announced results of a preclinical trial demonstrating the effectiveness of its calcium phosphate nanoparticulate (CAP) delivery system for the administration of drugs...

Effort Begins To Vaccinate 9 Million Afghan Kids For Measles.(Brief Article)
January 23, 2002... 2002 JAN 23 - (NewsRx.com & NewsRx.net) -- A coalition of groups have kicked off an immunization program to vaccinate 9 million Afghan children against measles. The vaccinations will be aimed at children between 6 months and 12 years old....

Mucosal Administration Can Improve Vaccine Efficacy.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Mucosal administration of HIV vaccines can improve the protection they offer, researchers in the United States report. Igor M. Belyakov and colleagues at...

Vaccine Failure Rate In Segment Of Chinese Population Elucidated.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A Chinese investigation of vaccine escape mutants in adults indicates the vaccine failure rate following hepatitis B virus (HBV) immunization in adults is low...

DNA Prime With Sendai Virus Booster Effective.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A Sendai virus-based HIV vaccine is effective when administered after a DNA prime, according to researchers in Japan. "Heterologous prime/boost regimens...

CDC To Survey Military Personnel On Anthrax Vaccine Worry.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- The U.S. Centers for Disease Control and Prevention is preparing to survey military personnel about the anthrax vaccine in hopes of learning how fears about its safety can be lessened. The...

Reinforced Hepatitis B Vaccine Schedule Fails In Organ Recipients.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A reinforced hepatitis B virus (HBV) vaccine schedule that is believed to prevent posttransplantation infection in liver transplant recipients has failed in a...

Mutant Vaccinia Virus Attacks Tumor Targets, Ignores Resting Cells.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - U.S. government investigators at the National Institutes of Health say they have enhanced the tumor specificity of vaccinia virus in order to increase its...

Data Suggest AIDSVAX B/B Induces Broad Immune Response To Common Subtypes.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., announced that published findings suggest it's HIV/AIDS vaccine, AIDSVAX B/B, induces antibodies to the five most common HIV subtypes. The article, by Sandra A. Lee and coauthors of...

GenVec, Inc., U.S. NIAID Partner To Develop AIDS Prevention Vaccines.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., announced January 10, 2002, that it has signed a letter contract authorizing it to commence work for the Vaccine Research Center at the U.S. National Institute of Allergy and Infectious...

Genencor Forms Strategic Collaboration With Johns Hopkins.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) has formed a two-year extendable collaboration with the Johns Hopkins University School of Medicine (JHU) for the research of therapeutic vaccines and other...

CancerVax Submits IND Application for Canvaxin.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- CancerVax Corp. has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a pivotal (Phase II/III) clinical trial of the Canvaxin...

Merck & Co. Cited By FDA For Problems At Vaccine Plant.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Merck & Co. has been cited twice by the U.S. Food and Drug Administration for quality-control problems at a Pennsylvania plant where a number of vaccines are produced. The Star-Ledger of Newark,...

Antiviral Therapies Promise Significant Treatment Rewards.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., announced the publication of "Hepatitis B Virus," a new study that explains why, despite considerable progress in the prevention and treatment of this disease, the hepatitis B...

Physicians Say All Babies Need Hepatitis Vaccine.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- All U.S. newborns should be vaccinated against hepatitis B before leaving the hospital to protect against possible disease from infected mothers, doctors recommend. Previously, giving the shots in...

Positive Phase III Results From Novel Two-Dose Vaccine Reported.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Rhein Biotech, N.V., and Corixa Corporation announced positive preliminary efficacy results of a Phase III clinical trial with a novel two-dose hepatitis B vaccine. The new vaccine is based on...

Vaccine Clinical Trials Underway.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., announced its multipronged tumor vaccine clinical program for the treatment of a variety of tumors, including advanced or incurable malignant melanoma. Phase I/II clinical trials of...

Avax Technologies Awarded Patent on O-Vax.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) has been granted U.S. Patent No. 6,333,028 from the U.S. Patent and Trademark Office, titled "Composition and Method of Using Tumor Cells." The patent applies to the...

Multiple Vaccines Do Not Weaken Or Overwhelm Infants Immune Systems.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- From the moment of birth, infants are capable of responding to numerous challenges to the immune system, including multiple vaccines, according to a new report. The report, authored by Paul A....

International Experts Call For New Strategy To Prevent Infant Deaths.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Parents and grandparents could be inadvertently putting their childrens' lives at risk, according to a new report from the International Consensus Group on Pertussis Immunisation. The report...

Phase II Clinical Trials Begin For Vaccine Therapy.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- Onyvax, Ltd., has initiated a Phase II clinical trial with its lead product, Onyvax P, in patients with prostate cancer who have failed hormone therapy. The trial will take place at St. George's...

United Kingdom Launches Infectious Diseases Strategy.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- The United Kingdom Chief Medical Officer Sir Liam Donaldson has announced plans for a new National Infection Control and Health Protection Agency to streamline the services involved in the prevention...

Hepatitis A and B Vaccination Now Required for Nevada School-Age Children.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- All children entering public and private schools for the first time in Nevada are required to be vaccinated against hepatitis A and B, the Nevada State Health Division has announced. The...

Missouri Begins Clinical Trials In Children.(Brief Article)
January 30, 2002... 2002 JAN 30 - (NewsRx.com & NewsRx.net) -- A clinical study to prevent rotavirus in children began Jan. 9 in Missouri. Officials at Jefferson City Medical Group said thousands of Missouri children contract the virus each year, which can...